We counted the proportion of SOX9+ nuclei that were ERBB4+ in each donor and found a significantly decreased proportion of astrocytes that expressed ERBB4 (i.e. SOX9+ERBB4+ nuclei) among the AD donors (39.2%) compared to normal donors (60.3%) (Fig. 5g). This evidence concerns the gene SOX9 and Alzheimer disease.